Scout | FY26 ALS Therapeutic Idea Award: fund innovative, high-risk ideas for ALS drug or therapy discovery

nofo

FY26 ALS Therapeutic Idea Award: fund innovative, high-risk ideas for ALS drug or therapy discovery

This award supports new, hypothesis-driven, high-risk/high-reward ideas to advance amyotrophic lateral sclerosis (ALS) drug or therapy discovery. Projects should aim to produce preliminary, interpretable results that can enable future therapeutic research. Preliminary data may be included, but the proposal should mainly be strong because of the underlying approach.

Source

Agency: Dept. of the Army -- USAMRAA

Award

Total Funding: $10.1M

Dates

Open Date: May 4, 2026

Close Date: September 30, 2026

Eligibility

industry:research

Keywords

als research

therapeutic idea

high-risk high-gain

drug discovery

therapy discovery

hypothesis driven

preliminary data

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers